Speciality Medicines Ltd (NSE: SPML), ISIN INE0R0M01014 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
SPML last traded at ₹187.00 (+3.86%), with a 52-week range of ₹121.10 to ₹381.20 (as of 30 Jul 2026).
EquiSense Score (ECS): 75/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.